14
Jul

A Lifelong Dedication to Cancer

When Alison Petok was five years old, her Nana died of leukemia. “If she had been diagnosed a decade or two later, perhaps she would have survived due to the advances in blood cancer research,” Alison reflected. Years later in 2017, Alison was nominated as “Woman of the Year” by The Leukemia & Lymphoma Society …

4
May

Kathleen O’Doherty Joins SKCC In Joint Navigator Position

We are excited to announce that Kathleen O’Doherty, RN, BSN, OCN, has joined us in the role of Nursing Care Coordinator: Oncology Outreach, a joint navigator position between Main Line Health Cancer Care and The Sidney Kimmel Cancer Center at Jefferson. Kathleen will work closely with physicians and members of the multidisciplinary care teams at both institutions …

28
Apr

Opening Up Chromatin for Cell Differentiation

Two new studies from the laboratory of Alex Mazo, PhD, at the Sidney Kimmel Cancer Center, along with collaborators from SKCC, the Vickie and Jack Farber Institute for Neuroscience at Thomas Jefferson University, and other institutions, provide new insights into the structure of chromatin and its implications for cellular differentiation.  The new work, appearing in …

25
Apr

New Insights into G Protein-Coupled Receptor Signaling and Regulation

A collaborative study by the laboratories of Jeffrey L. Benovic, PhD,  in the Department of Biochemistry and Molecular Biology at Thomas Jefferson University and the Sidney Kimmel Cancer Center at Jefferson, and Dr. Brian K. Kobilka in the Department of Molecular and Cellular Physiology at the Stanford University School of Medicine provides new insights into a …

30
Mar

2017 Ocular Melanoma Foundation–AACR Fellowship Awarded to Vivian Chua

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce that Vivian Chua, PhD, has been awarded a 2017 Ocular Melanoma Foundation–American Associate for Cancer Research (AACR) Fellowship for her project, “Novel Epigenetic Targeting Approaches in Uveal Melanoma.” This one-year, $50,000 grant recognizes the significant impact of Dr. Chua’s research, its relevance to the …

29
Mar

Christine Bonaccorso Named Administrative Director of Sidney Kimmel Cancer Network

Please join us in congratulating Christine Bonaccorso, RN, BSN, OCN, on assuming the position of Administrative Director of the Sidney Kimmel Cancer Network. Over the past several months, Bonaccorso has proven to be an outstanding leader while serving as Interim Director, playing a critical role in several projects that have greatly enhanced the Cancer Network. …

24
Mar

Noelle Williams Inducted into Gold Humanism Honor Society

The Sidney Kimmel Cancer Center at Jefferson would like to congratulate Noelle L. Williams, MD, who has been selected for induction into the Gold Humanism Honor Society Resident Chapter of Thomas Jefferson University. The Gold Humanism Honor Society recognizes students, residents, and faculty who are exemplars of compassionate patient care and who serve as role …

21
Mar

Unite for HER Wellness Day – April 2, 2017

  The Sidney Kimmel Cancer Center at Jefferson encourages Jefferson Hospital System breast cancer patients to participate in the upcoming “Unite for HER Wellness Day” event to be held on Sunday, April 2, 2017. This event will allow breast cancer patients to meet in a small group setting with trained professionals to learn about complementary …

15
Mar

RNA-Regulated Mechanism Validated as a Target in GI Tract Cancers

Investigators from the Sidney Kimmel Cancer Center at Jefferson, Thomas Jefferson University, and Drexel University have uncovered a critical regulatory mechanism involved in pancreatic and colorectal cancer progression. The study results were recently published in Molecular Cancer Research. The researchers investigated the role of the RNA-binding protein HuR (also known as ELAVL1) in gastrointestinal (GI) …

27
Jan

The Sidney Kimmel Cancer Center at Jefferson Welcomes Pierluigi Porcu

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce the appointment of Pierluigi Porcu, MD, as the new Director of the Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Division in the Department of Medical Oncology, effective December 1, 2016. Dr. Porcu comes to Jefferson from The Ohio State University in Columbus, where he …

18
Jan

Doylestown Health Joins Sidney Kimmel Cancer Network at Jefferson

The Sidney Kimmel Cancer Network at Jefferson and Doylestown Health will officially join forces effective January 1, 2017. The affiliation combines the expertise of a leading academic medical center and a community health system with a reputation for delivering quality health care. As the newest member of the Sidney Kimmel Cancer Network (SKCN) at Jefferson, …

13
Jan

Maria Werner-Wasik Receives New Jefferson Appointments

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce that Maria Werner-Wasik, MD, FASTRO, has been appointed to the position of Executive Vice Chair for Radiation Oncology Integration and the Walter Curran Professor of Radiation Oncology.  As the Executive Vice Chair, she will focus her activities on harmonizing and integrating all clinical radiation …

7
Dec

Jefferson Breast Cancer Researcher Named Margaret Q. Landenberger Professor

Nicole Simone, MD, has been named the Margaret Q. Landenberger Professor. The professorship, which focuses on breast cancer research, was established in 2006 by the Margaret Q. Landenberger Research Foundation. Dr. Simone will be the second holder of the professorship. “Dr. Simone is a cancer research pioneer who has dedicated her entire career to discovering …

7
Sep

Teen Wraps Cancer Patients in Love

Like many teenagers, Eve Korus, 17, has a lot on her plate. The Westport, Conn. high school senior keeps busy with homework, college planning, and soccer, but she still finds time to give back to the community — especially patients undergoing chemotherapy treatment for cancer. On Aug. 30, patients and employees at the Jefferson Infusion …

23
Sep

Genomic Analysis for All Cancer Patients

09/17/15 Jefferson expands its cancer treatment to analyze each cancer patient’s tumor with the newest techniques and help doctors identify cutting edge treatment options. (PHILADELPHIA) – Cancer medicine is moving towards understanding what drives each particular patient’s cancer. But not every patient has had access to this level of individualized care. Today, Jefferson announced its …

23
Dec

Infusion Center Toy Drive

Jefferson Oncology Infusion Program staff  held a toy drive during the month of December were they collected over 100 toys to help Pediatric Oncology patients in the Philadelphia area.

22
Oct

2014 SKCC Consortium: Symposium and Poster Session

On October 1st, 2014 the Sidney Kimmel Cancer Center Consortium held a Symposium and Poster Session. Senior Leadership presented overviews of the work being done across the Sidney Kimmel Cancer Center Consortium. Also, progress reports were presented by the recipients of the 2013 SKCC Consortium Pilot Project Awards.  The afternoon portion of the event was …

8
Sep

Sidney Kimmel Cancer Center at Jefferson Tribute Dinner Hosted By Phialdelphia Eagles at Lincoln Financial Field

The Sidney Kimmel Cancer Center at Thomas Jefferson University held its annual tribute Dinner on September 5th, 2014. The honorees of the annual event were he Philadelphia Eagles for their effort to fight Cancer. The event was held at Lincoln Financial Field. Proceeds from the event will benefit the Cancer Breakthrough Research Fund. For more …

12
Dec

Jefferon’s Kimmel Cancer Center Holds 5th Annual Men’s Event

Jefferson’s Kimmel Cancer Center hosted its 5th Annual Men’s Event to benefit prostate cancer research and awareness at the Prime Rib Restaurant on November 14. Below are some photos of the night, award ceremony and entertainment provided by Comedy Central’s “100 Greatest Stand-Ups of All Time,” Jim Breuer of Saturday Night Live.

23
Aug

Researchers Find New Clues to Treat Rare and Aggressive Inflammatory Breast Cancer

A study led by investigators from Thomas Jefferson University’s Kimmel Cancer Center has discovered molecular clues that may help physicians therapeutically target inflammatory breast cancer (IBC), a highly aggressive form of breast cancer. Their study, reported in the June 21 online issue of Breast Cancer Research and Treatment, identified two molecules (ALK and FAK1) involved in the …

Page 1 of 3